FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for treating a paroxysmal form of atrial fibrillation in patients with chronic heart failure in arterial hypertension. That is ensured by prescribing drug-induced therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists, selective beta-adrenoreceptor blocking agent, mineralocorticoid receptor antagonists and additionally: a loop diuretic – torasemide in dose of 15–30 mg a day in two steps to normalize the maximum and minimum diameter of pulmonary veins and left atrial volume, magnesium orotate 1,500 mg, 3-unsaturated fatty acids in dose of 1,000 mg, vitamin C in dose of 200 mg and vitamin E in dose of 400 mg a day.
EFFECT: method allows to stop atrial fibrillation paroxysms.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ULTRASONIC EARLY DIAGNOSIS OF VENOUS PULMONARY HYPERTENSION FOR PATIENTS WITH CHRONIC HEART FAILURE | 2016 |
|
RU2634633C2 |
| METHOD OF TREATING PATIENTS WITH RADIATION EXUDATIVE PERICARDITIS | 2009 |
|
RU2415667C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| METHOD FOR PREDICTING THE SURVIVAL OF A PATIENT WITH CHRONIC HEART FAILURE WITH A LOW LEFT VENTRICULAR EJECTION FRACTION FOR 1 YEAR | 2017 |
|
RU2646750C9 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| METHOD OF PREDICTING RECOVERY OF SINUS RHYTHM IN PEOPLE WITH PERSISTING ATRIAL FIBRILLATION WITH METABOLIC SYNDROME | 2010 |
|
RU2436518C1 |
| METHOD OF IMMUNOLOGICAL PREDICTION OF SUDDEN CORONARY DEATH | 2023 |
|
RU2810015C1 |
| METHOD FOR TREATING DOGS WITH DILATED CARDIOMYOPATHY COMPLICATED BY CONGESTIVE CARDIAC FAILURE | 2020 |
|
RU2762989C1 |
| METHOD FOR PHARMACOLOGICAL AUTONOMIC HEART BLOCK | 2014 |
|
RU2572339C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
